Bellerophon Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $22,384,000.
Profit Margin
| 2013 | 0 | -61.99M | |
|---|---|---|---|
| 2014 | 0 | -59.67M | |
| 2015 | 0 | -46.45M | |
| 2016 | 0 | -23.81M | |
| 2017 | 0 | -54.81M | |
| 2018 | 0 | 2.81M | |
| 2019 | 0 | -13.26M | |
| 2020 | 0 | -24.72M | |
| 2021 | 0 | -17.75M | |
| 2022 | 0 | -19.83M |
BLPH Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 147K | 0 | 0 | 373K | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | -147K | 0 | 0 | -373K | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 16.36M | 13.01M | 17.89M | 11.03M | 20.25M | 17.85M | 16.65M | 33.36M | 45.97M | 52.98M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.38M | 20.16M | 26.27M | 17.47M | 27.88M | 24.59M | 23.75M | 46.56M | 59.75M | 61.99M |
Operating income | -22.38M | -20.16M | -26.27M | -17.47M | -27.88M | -24.59M | -23.75M | -46.56M | -59.75M | -61.99M |
Other income (expenses), net | 136K | 605K | -577K | 2.40M | 24.87M | -30.21M | -590K | 402K | 79K | 0 |
Income before tax | -22.24M | -19.55M | -26.85M | -15.06M | -2.62M | -54.81M | -24.25M | -46.45M | -59.67M | -61.99M |
Income tax expense | -2.41M | -1.8M | -2.12M | -1.80M | -5.43M | 29.84M | -438K | 1.18M | 0 | 0 |
Net income | -19.83M | -17.75M | -24.72M | -13.26M | 2.81M | -54.81M | -23.81M | -46.45M | -59.67M | -61.99M |
Earnings per share | ||||||||||
Basic EPS | -2.08 | -1.87 | -3.17 | -2.95 | 0.65 | -21.11 | -23.72 | -56.81 | -5.01 | -4.8 |
Diluted EPS | -2.08 | -1.87 | -3.17 | -2.95 | 0.65 | -21.11 | -23.72 | -56.81 | -5.01 | -4.8 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |